155 related articles for article (PubMed ID: 37895007)
61. Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels.
Ohya M; Yashiro M; Sonou T; Okuda K; Tatsuta K; Mima T; Tone Y; Negi S; Saika Y; Shigematsu T
Contrib Nephrol; 2018; 196():44-51. PubMed ID: 30041203
[TBL] [Abstract][Full Text] [Related]
62. Bone-kidney axis in systemic phosphate turnover.
Razzaque MS
Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
[TBL] [Abstract][Full Text] [Related]
63. The synthesis of fibroblast growth factor 23 is upregulated by homocysteine in UMR106 osteoblast-like cells.
Alber J; Freisinger P; Föller M
Nutrition; 2022 Apr; 96():111573. PubMed ID: 35091320
[TBL] [Abstract][Full Text] [Related]
64. Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23.
McCarty MF
Med Hypotheses; 2017 Feb; 99():68-72. PubMed ID: 28110703
[TBL] [Abstract][Full Text] [Related]
65. Rapid and sensitive detection of maize chlorotic mottle virus using surface plasmon resonance-based biosensor.
Zeng C; Huang X; Xu J; Li G; Ma J; Ji HF; Zhu S; Chen H
Anal Biochem; 2013 Sep; 440(1):18-22. PubMed ID: 23660014
[TBL] [Abstract][Full Text] [Related]
66. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.
Grigore TV; Zuidscherwoude M; Witasp A; Barany P; Wernerson A; Bruchfeld A; Xu H; Olauson H; Hoenderop J
Front Endocrinol (Lausanne); 2022; 13():1046392. PubMed ID: 36699036
[TBL] [Abstract][Full Text] [Related]
67. FGFR3 and FGFR4 do not mediate renal effects of FGF23.
Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD
J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255
[TBL] [Abstract][Full Text] [Related]
68. 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.
Yamamoto R; Minamizaki T; Yoshiko Y; Yoshioka H; Tanne K; Aubin JE; Maeda N
J Endocrinol; 2010 Sep; 206(3):279-86. PubMed ID: 20530653
[TBL] [Abstract][Full Text] [Related]
69. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.
Nelson AE; Bligh RC; Mirams M; Gill A; Au A; Clarkson A; Jüppner H; Ruff S; Stalley P; Scolyer RA; Robinson BG; Mason RS; Bligh PC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4088-94. PubMed ID: 12970268
[TBL] [Abstract][Full Text] [Related]
70. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
71. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Yu X; Sabbagh Y; Davis SI; Demay MB; White KE
Bone; 2005 Jun; 36(6):971-7. PubMed ID: 15869926
[TBL] [Abstract][Full Text] [Related]
72. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
73. FGF23 functions and disease.
Cipriani C; Minisola S; Colangelo L; DE Martino V; Ferrone F; Biamonte F; Danese V; Sonato C; Santori R; Occhiuto M; Pepe J
Minerva Endocrinol (Torino); 2022 Dec; 47(4):437-448. PubMed ID: 33792238
[TBL] [Abstract][Full Text] [Related]
74. Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.
Courbon G; Martinez-Calle M; David V
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):359-366. PubMed ID: 32452919
[TBL] [Abstract][Full Text] [Related]
75. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
[TBL] [Abstract][Full Text] [Related]
76. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
Imel EA; Econs MJ
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
[TBL] [Abstract][Full Text] [Related]
77. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.
Kosk D; Kramer H; Luke A; Camacho P; Bovet P; Rhule JP; Forrester T; Wolf M; Sempos C; Melamed ML; Dugas LR; Cooper R; Durazo-Arvizu R
J Bone Miner Metab; 2017 Nov; 35(6):666-674. PubMed ID: 27942978
[TBL] [Abstract][Full Text] [Related]
78. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.
Ewendt F; Feger M; Föller M
Front Cell Dev Biol; 2020; 8():601006. PubMed ID: 33520985
[TBL] [Abstract][Full Text] [Related]
79. Association between the intake of plant and animal proteins and the serum fibroblast growth factor-23 level in patients with chronic kidney disease analyzed by the isocaloric substitution model.
Yoshioka M; Kosaki K; Matsui M; Mori S; Nishitani N; Saito C; Yamagata K; Kuro-O M; Maeda S
Endocr J; 2023 Jan; 70(1):31-42. PubMed ID: 36058847
[TBL] [Abstract][Full Text] [Related]
80. Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation.
Takashi Y; Kosako H; Sawatsubashi S; Kinoshita Y; Ito N; Tsoumpra MK; Nangaku M; Abe M; Matsuhisa M; Kato S; Matsumoto T; Fukumoto S
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11418-11427. PubMed ID: 31097591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
